Chu Yu-Waye (CIK 1854586) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-19). Recent activity: Sell CTMX (21,279 shares), Buy CTMX (75,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | CytomX Therapeutics, Inc. (CTMX) | Chief Medical Officer | Sell | 21,279 | $136,611 |
| 2026-02-04 | CytomX Therapeutics, Inc. (CTMX) | Chief Medical Officer | Buy | 75,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-03-19